ALPHA (0303) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ALPHA (0303) has a cash flow conversion efficiency ratio of 0.054x as of November 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM11.01 Million ≈ $2.76 Million USD) by net assets (RM202.29 Million ≈ $50.79 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 0303 market cap for the company's overall valuation and market capitalisation.
ALPHA - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how ALPHA's cash flow conversion efficiency has evolved over time, based on yearly financial data.
ALPHA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ALPHA ranked by their cash flow conversion efficiency. Explore how high is ALPHA's earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Immuneering Corp
NASDAQ:IMRX
|
-0.053x |
|
CapMan Oyj B
HE:CAPMAN
|
0.066x |
|
Mirae Asset Venture Investment Co. Ltd
KQ:100790
|
-0.001x |
|
Propel Funeral Partners Ltd
AU:PFP
|
0.059x |
|
SUNDARAM CLAYTON LTD
NSE:SUNCLAY
|
0.029x |
|
Know Labs Inc.
NYSE MKT:KNW
|
0.269x |
|
STP&I Public Company Limited
BK:STPI
|
0.040x |
|
Hunan Baili Engineering Sci
SHG:603959
|
0.820x |
Annual Cash Flow Conversion Efficiency for ALPHA (2020–2025)
The table below shows the annual cash flow conversion efficiency of ALPHA from 2020 to 2025. View latest ALPHA stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-05-31 | RM204.15 Million ≈ $51.25 Million |
RM54.91 Million ≈ $13.79 Million |
0.269x | -13.55% |
| 2024-05-31 | RM189.78 Million ≈ $47.65 Million |
RM59.05 Million ≈ $14.83 Million |
0.311x | -71.99% |
| 2023-05-31 | RM54.55 Million ≈ $13.70 Million |
RM60.61 Million ≈ $15.22 Million |
1.111x | +90.88% |
| 2022-05-31 | RM58.97 Million ≈ $14.80 Million |
RM34.32 Million ≈ $8.62 Million |
0.582x | +152.19% |
| 2021-05-31 | RM48.57 Million ≈ $12.19 Million |
RM11.21 Million ≈ $2.81 Million |
0.231x | -72.30% |
| 2020-05-31 | RM28.36 Million ≈ $7.12 Million |
RM23.63 Million ≈ $5.93 Million |
0.833x | -- |
About ALPHA
Alpha IVF Group Berhad, together with its subsidiaries, operates as a fertility care specialist that focuses on the provision of assisted reproductive services in Malaysia, Singapore, Indonesia, China, Middle East, the Philippines, and internationally. The company offers assisted reproductive treatment services comprising ovulation induction, intra-uterine insemination, in-vitro fertilization tre… Read more